Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |